News

June 17, 2010 – AGA Medical Holdings Inc. this week announced first patient enrollment in the feasibility phase of the prospective, multicenter, randomized Amplatzer Cardiac Plug clinical trial....

June 16, 2010 – A new surgical device for excluding the left atrial appendage has received clearance from the U.S. Food and Drug Administration (FDA). AtriCure Inc. announced this week that it...

March 29, 2010 – A lawsuit was settled between Medtronic and AGA Medical Corp. for the alleged infringement of patents concerning the use of stress to restrain self-expanding nitinol medical...

March 25, 2010 – The FDA this week granted permission for a conditional investigational device exemption (IDE) to evaluate the safety and efficacy of a transcatheter plug to seal the left atrial...

October 8, 2009 – A five-judge panel in the German Federal Patent Court in Munich upheld the validity of an AGA Medical Holdings’ patent for its AMPLATZER occlusion devices and the manufacturing...

September 17, 2009 – NMT Medical Inc. said yesterday it will commence data analysis for its landmark STARFlex patent foramen ovale (PFO)/stroke and transient ischemic attack (TIA) clinical trial,...

August 24, 2009 – Physicians at The Mount Sinai Medical Center were the first in the country to perform a nonsurgical procedure using sutures to tie off a left atrial appendage (LAA), which is the...

July 31, 2009 – A United Kingdom court has determined Occlutech GmbH’s products do not infringe on AGA Medical Holdings’ patents for atrial septal defects (ASD) and patent foramen ovale (PFO)...

May 11, 2009 - Medtronic Inc. today announced the successful implant of its Cardioblate Closure Left Atrial Appendage Occlusion Device by Patrick McCarthy, M.D., co-director of the Bluhm...

April 10, 2009 - NMT Medical Inc. said this week data analysis for its STARFlex device for patent foramen ovale (PFO)/stroke and transient ischemic attack (TIA) clinical trial, CLOSURE I, will...

April 2, 2009 - A device implanted in the heart using minimally invasive techniques may replace the most widely prescribed drug for stroke prevention in patients with nonvalvular atrial...

March 6, 2009 - Atritech Inc. will release PROTECT AF trial results on WATCHMAN LAA closure technology comparing the device to the current standard of care, warfarin therapy, in patients with non...

March 5, 2009 - Reducing the frequency and severity of disabling migraines is crucial for quality of life and a new study, published in the February 2009 issue of JACC: Cardiovascular...

March 4, 2009 - W. L. Gore & Associates has earned a spot on Fast Company magazine’s 2009 “Fast 50” list of the world’s most innovative companies, partly for its development of the GORE HELEX...

February 5, 2009 - AGA Medical Corp. last week said following its previous favorable structural heart occluder patent infringement final ruling by the German court of appeals over Occlutech GmbH...

December 22, 2008 - W. L. Gore & Associates last week said Rush University Medical Center in Chicago is the first medical center to enroll a patient in the Gore REDUCE Clinical Study using the...

August 18, 2008 - Atritech Inc. today said it filed its pre-market approval application (PMA) with the FDA for its WATCHMAN Left Atrial Appendage (LAA) Closure Technology, which contains the...

February 11, 2008 – A new minimally invasive vascular occlusion device designed to close a patent ductus arteriosus (PDA) received European CE Mark approval.

January 30, 2008 - Aporo Biomedical signed an exclusive global licensing agreement with mNEMOSCIENCE GmbH for its proprietary biodegradable shape memory polymers (BIO-SMP), enabling Aporo to offer...

January 7, 2008 - Cardica Inc. received nearly $2 million in payments from Cook Medical (Cook) for reaching milestones pursuant to its development agreements with Cook, including a vascular...